Purine-containing compound transmembrane transport

pathway activity — cross-omics
GO:0072530Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Purine-containing compound transmembrane transport pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are WAS, LCP2, and LPXN, each associated with the pathway in up to 9 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Purine-containing compound transmembrane transport activity versus WAS in GBM (Pearson r = 0.45).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMWAS →+0.431+0.033<.001<.00139
UCECLCP2 →+0.523+0.051<.001<.00138
GBMLPXN →+0.650+0.044<.001<.00138
GBMLSP1 →+0.665+0.037<.001<.00138
UCECWIPF1 →+0.424+0.041<.001<.00138
LSCCALOX5 →+0.486+0.043<.001<.00138
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0072530 vs WAS — GBM

Per-sample scatter of Purine-containing compound transmembrane transport activity vs WAS in GBM.

Explore this scatter interactively →

Exploration